Benfosformin anhydrous

This classification denotes the anhydrous form of an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49030P3C8S. European Medicines Agency schedules Benfosformin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05715MIG. Benfosformin generally arises in the molecular formula C9H12N5O3P.2NA.H2O. The term BENFOSFORMIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 27, no. 10 1973, list 13.) BENFOSFORMIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule benfosformin anhydrous under HS 29299000. As of Q4 2014, BENFOSFORMIN ANHYDROUS remains US FDA's Preferred Term for this commodity. Benfosformin anhydrous bears US NLM identifiers UMLS ID C2698357 and NCI Concept Code C79537. SMILES: C1CCC(CC1)CNC(=N)NC(=N)NP(=O)([O-])[O-].[NA+].[NA+].